Literature DB >> 33461901

Current Challenges for Fasciolicide Treatment in Ruminant Livestock.

José Antonio Castro-Hermida1, Marta González-Warleta1, Victoria Martínez-Sernández2, Florencio M Ubeira2, Mercedes Mezo3.   

Abstract

Pharmacological treatment remains essential to control fasciolosis in areas where infection is endemic. However, there are major constraints to treating food-producing animals. Of particular concern is the lack of flukicides for treating early Fasciola infections in ruminant livestock in some countries. In addition, the information provided in package leaflets, particularly regarding withdrawal periods, is often incomplete, confusing, and/or contradictory. International regulatory bodies should harmonize the use of flukicides in livestock in favor of fairer, safer international trade. In addition, monitoring the efficacy of fasciolicides on farms is also essential to minimize the spread of drug-resistant populations of Fasciola. The current situation regarding flukicide formulations in the European Union and other, non-European countries is analyzed in this review paper.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fasciola; anthelmintic; flukicide; ruminant; triclabendazole; veterinary drug

Year:  2021        PMID: 33461901     DOI: 10.1016/j.pt.2020.12.003

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  4 in total

1.  The Differences in the Susceptibility Patterns to Triclabendazole Sulfoxide in Field Isolates of Fasciola hepatica Are Associated with Geographic, Seasonal, and Morphometric Variations.

Authors:  Martha V Fernandez-Baca; Cristian Hoban; Rodrigo A Ore; Pedro Ortiz; Young-Jun Choi; César Murga-Moreno; Makedonka Mitreva; Miguel M Cabada
Journal:  Pathogens       Date:  2022-05-28

2.  Timing of Transcriptomic Peripheral Blood Mononuclear Cell Responses of Sheep to Fasciola hepatica Infection Differs From Those of Cattle, Reflecting Different Disease Phenotypes.

Authors:  Dagmara A Niedziela; Amalia Naranjo-Lucena; Verónica Molina-Hernández; John A Browne; Álvaro Martínez-Moreno; José Pérez; David E MacHugh; Grace Mulcahy
Journal:  Front Immunol       Date:  2021-09-20       Impact factor: 7.561

3.  Targeting Secreted Protease/Anti-Protease Balance as a Vaccine Strategy against the Helminth Fasciola hepatica.

Authors:  Krystyna Cwiklinski; Orla Drysdale; Jesús López Corrales; Yolanda Corripio-Miyar; Carolina De Marco Verissimo; Heather Jewhurst; David Smith; Richard Lalor; Tom N McNeilly; John P Dalton
Journal:  Vaccines (Basel)       Date:  2022-01-20

4.  Field evaluation of the enhanced MM3-COPRO ELISA test for the diagnosis of Fasciola hepatica infection in sheep.

Authors:  Mercedes Mezo; Marta González-Warleta; José Antonio Castro-Hermida; Victoria Martínez-Sernández; Florencio M Ubeira
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.